Jane Street Group LLC acquired a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 30,829 shares of the company's stock, valued at approximately $567,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of ARDT. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the third quarter worth $42,000. Financial Management Professionals Inc. bought a new position in Ardent Health Partners in the third quarter valued at about $50,000. MetLife Investment Management LLC bought a new position in shares of Ardent Health Partners in the 3rd quarter valued at about $135,000. Quadrature Capital Ltd bought a new stake in shares of Ardent Health Partners during the third quarter worth approximately $229,000. Finally, Centiva Capital LP acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at $469,000.
Ardent Health Partners Stock Performance
ARDT stock traded down $0.78 during trading hours on Monday, reaching $15.86. The stock had a trading volume of 280,838 shares, compared to its average volume of 299,809. The company's 50-day moving average is $16.71. Ardent Health Partners, LLC has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ARDT. Stephens reiterated an "overweight" rating and issued a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. Truist Financial reduced their price objective on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research report on Monday. Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and dropped their target price for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. KeyCorp began coverage on Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target for the company. Finally, Leerink Partners lifted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a report on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $22.00.
Read Our Latest Analysis on Ardent Health Partners
Ardent Health Partners Profile
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
